A Kentucky mom is the first person in the state to use an experimental drug to hopefully extend her life after a Stage IV ...
Oncologists know that intensive treatment rarely helps patients in their final days, but recognizing when someone is entering ...
The findings show that cancer patients who completed 70 percent of their exercise program had much better survival odds.
Dr. Lamas, a contributing Opinion writer, is a pulmonary and critical care physician at Brigham and Women’s Hospital in Boston. See more of our coverage in your search results.Encuentra más de nuestra ...
Standard adjuvant chemotherapy for stage III colon cancer consists of a fluoropyrimidine-plus-oxaliplatin regimen. Whether the addition of atezolizumab (an anti–programmed death ligand 1 agent) to a ...
Trial extension completed as planned with three-year clinical efficacy data expected to be presented in the second half of 2026 COPENHAGEN, Denmark, April 7, 2026 - Evaxion A/S (NASDAQ: EVAX) ...
Trials are designed with patient safety in mind while helping researchers determine whether a new treatment is safe and effective. Some cancer trials do use a placebo, an inactive pill, but patients ...
New findings could shift the standard approach to preventing brain metastases in SCLC, particularly as modern MRI allows clinicians to detect and treat brain disease earlier.
A phase 1 trial treated 15 patients with breast cancer that spread to the spinal fluid using a vaccine made from their own immune cells. One patient is now more than three years from diagnosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results